Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Preprints with The Lancet are here to stay
2 COVID-19: a stress test for trust in science
3 Understanding Mexican health worker COVID-19 deaths
4 Brazil's COVID-19 response
5 Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study
6 Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly
7 A case of probable Parkinson's disease after SARS-CoV-2 infection
8 Learning from a retraction
9 Department of Error
10 Lessons from a neurology consult service for patients with COVID-19
11 A history of herd immunity
12 Lancet Medical Journal Changes Peer-Review Process Amid Flurry of Covid-19 Research
13 The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion
14 Global collaboration for health: rhetoric versus reality
15 COVID-19 public health measures and respiratory syncytial virus
16 Artificial intelligence in COVID-19 drug repurposing
17 Intention to vaccinate against COVID-19 in Australia
18 NeuroCOVID: it's time to join forces globally
19 Associations between phone mobility data and COVID-19 cases
20 Addressing racial inequalities in a pandemic: data limitations and a call for critical analyses
21 Curing COVID-19
22 Projected health-care resource needs for an effective response to COVID-19 in 73 low-income and middle-income countries: a modelling study
23 Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study
24 COVID-19 and diabetes: a co-conspiracy?
25 Promotion of scientific research on COVID-19 in Turkey
26 Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
27 COVID-19 vaccines: early success and remaining challenges
28 Guiding better design and reporting of AI-intervention trials
29 COVID-19 and readjusting clinical trials
30 The Lancet Oncology at 20—two decades of influencing the oncology landscape
31 Cortisol concentrations and mortality from COVID-19 – Authors' reply
32 Publishing Excellence
33 Transparency during global health emergencies
34 Surveillance is underestimating the burden of the COVID-19 pandemic
35 COVID-19 vaccine trials should seek worthwhile efficacy
36 Clinical research: further COVID-19 collateral damage
37 COVID-19: a new lens for non-communicable diseases
38 Italy's first wave of the COVID-19 pandemic has ended: no excess mortality in May, 2020
39 Vision 2020: looking back and thinking forward on The Lancet Oncology Commissions
40 Mavrilimumab for severe COVID-19
41 Is India missing COVID-19 deaths?
42 Setting sights and giving thanks
43 Immediate impact of stay-at-home orders to control COVID-19 transmission on socioeconomic conditions, food insecurity, mental health, and intimate partner violence in Bangladeshi women and their families: an interrupted time series
44 In preparation for a COVID-19-influenza double epidemic
45 COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
46 Delving beneath the surface of hyperinflammation in COVID-19
47 COVID-19 and haematology-oncology services
48 Correction to Lancet Rheumatol 2020; published online June 25.
49 Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
50 Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access
51 Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey
52 COVID-19 exacerbates violence against health workers
53 20 years of The Lancet Oncology: how scientific should oncology be?
54 Graduate public health education in the post-COVID-19 era
55 Bangladesh's COVID-19 testing criticised
56 Bringing hospital care closer to patients amidst COVID-19
57 Interpreting big-data analysis of retrospective observational data
58 Hear from Lancet editor-in-chief on study into Russia's vaccine
59 Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
60 The universal health coverage ambition faces a critical test
61 Responding to COVID-19 requires strong epidemiological evidence of environmental and societal determining factors
62 Will the COVID-19 pandemic threaten the SDGs?
63 Azithromycin for severe COVID-19
64 When to consider lung transplantation for COVID-19
65 Trump versus Biden: a fight for the health of a nation
66 SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
67 Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial
68 Understanding clinical decision-making during the COVID-19 pandemic: A cross-sectional worldwide survey
69 Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial
70 Russia's potential coronavirus vaccine shows 'no serious adverse' effects and creates antibody response: The Lancet study
71 Multisystem inflammatory syndrome in children: A systematic review
72 Sputnik V research team responds to criticism in The Lancet
73 Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
74 Asthma 2020
75 Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study
76 COVID-19 vaccines and neglected pregnancy
77 Multisystem inflammatory syndrome in children in South Africa
78 Researchers highlight 'questionable' data in Russian coronavirus vaccine trial results
79 SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic's COVID-19 registry
80 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
81 How is Rising Incidence of Diabetes Propelling Progress of Global Lancet Market?
82 Scientists flag gaps in Lancet study that claimed success of Russian Covid vaccine Sputnik V
83 Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
84 Effect of the COVID-19 pandemic on viral hepatitis services in sub-Saharan Africa
85 Lebanon's humanitarian crisis escalates after the Beirut blast
86 Case of probable Parkinsons disease after COVID-19 infection reported in Lancet
87 A locally sustainable approach to COVID-19 testing in Africa
88 Investigation of SARS-CoV-2 outbreaks in six care homes in London, April 2020
89 Leading Scientists Question 'Highly Improbable' Russian Vaccine Results Published in Lancet
90 Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study
91 SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19
92 Blood Lancet Market to Witness Exponential Growth by 2020-2027 | Leading Players – Becton Dickinson, Improve Medical, Terumo, Sarstedt, FL Medical, Medtronic, Haemonetics, Shangdong Lianfa Medical
93 Scientists to examine possibility Covid leaked from lab as part of investigation into virus origins
94 Landiolol effective remedy for sepsis-related tachyarrhythmias: Lancet
95 Reviving the US CDC
96 Russian Covid-19 vaccine triggers immune response: Lancet
97 One-hour British DnaNudge COVID-19 test is accurate, study finds
98 BioMarin Announces The Lancet Publishes Detailed Vosoritide Phase 3 Data Demonstrating Statistically Significant Increase in Annualized Growth Velocity (AGV) Over 52 Weeks in Children with Achondroplasia
99 Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
100 Offline: Don't let COVID-19 divert us completely